New Insulin Manufacturer For Civica
Civica Enlists Swiss Ypsomed To Make Injector Pens
Ypsomed AG will manufacture insulin dosing injector pens for non-profit Civica. Civica has also paired up with AmerisourceBergen for generics supply chain support across the US.
You may also be interested in...
As it continues plans to roll out low-cost insulin biosimilar products, CivicaScript has augmented its existing product offering via a collaboration with specialty pharmacy SortPak.
Civica is set to provide biosimilar insulins to the state of California through its CalRx program, following approval from the US Food and Drug Administration.
Biosimilar insulin producers are facing calls to improve patient affordability after Eli Lilly implemented a $35 price cap on copays for its insulins in the private market and for the uninsured.